Leaky channels make weak muscles

Alfred L George1

  • 1Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA. al.george@vanderbilt.edu

Insights

Mutations in the skeletal muscle calcium channel (CaV1.1) cause hypokalemic periodic paralysis. A new mouse model reveals aberrant gating pore currents, explaining muscle membrane depolarization and paralysis.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • Mutations in the skeletal muscle voltage-gated calcium channel (CaV1.1) are linked to hypokalemic periodic paralysis.
  • The precise relationship between CaV1.1 mutations and the disorder's pathogenesis remained unclear.

Purpose of the Study:

  • To investigate the cellular and molecular mechanisms underlying hypokalemic periodic paralysis caused by CaV1.1 mutations.
  • To establish a CaV1.1 mutant mouse model that recapitulates the disease.

Main Methods:

  • Generation of a novel knock-in CaV1.1 mutant mouse model.
  • Electrophysiological analysis of muscle cell currents and membrane potential.
  • Investigation of molecular features of pathogenesis during paralysis provocation.

Main Results:

  • Demonstrated aberrant muscle cell current (gating pore current) conducted through the CaV1.1 voltage-sensor domain.
  • Explained abnormally depolarized muscle membrane potential in the mutant model.
  • Showed failure of muscle action potential firing during paralysis provocation.

Conclusions:

  • Aberrant gating pore currents in CaV1.1 are a key mechanism in hypokalemic periodic paralysis pathogenesis.
  • The CaV1.1 mutant mouse model provides insights into inherited channelopathies.
  • Advances understanding of molecular and cellular mechanisms underlying muscle channelopathies.

Related Concept Videos

Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Muscle Contraction01:10

Muscle Contraction

In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive muscle...
Muscle Contraction01:15

Muscle Contraction

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.